LALINDEN ADVISORS LP

Institutional investor · Portfolio as of Q3 2023

Top Holdings374 positions

Checking export access…
Activity:
??PINDUODUO INCDelisted
Bond
387.9M$383.1M3.9%———
Increased
57
??LI AUTO INCDelisted
Bond
201M$284.5M2.9%——
6 qtrssince 2022-Q2
Increased
64
??WOLFSPEED INCDelisted
Bond
263M$283.5M2.9%———
Decreased
0
??SEA LTDDelisted
274.6M$262.6M2.7%———
Unchanged
0
??MONGODB INCDelisted
Bond
110.9M$189.8M1.9%———
Increased
76
182.5M$183.7M1.9%———
Decreased
0
??BILIBILI INCDelisted
Bond
179.5M$178.2M1.8%——
14 qtrssince 2020-Q2
Unchanged
0
154.2M$172.8M1.8%———
New
70
??LIVONGO HEALTH, INC.Delisted
Bond
188.1M$172.2M1.8%———
Increased
55
??ROYAL CARIBBEAN GROUPDelisted
Bond
86.4M$170.6M1.8%———
New
69
??CONFLUENT INCDelisted
Bond
201.9M$165.4M1.7%———
Increased
55
214.7M$164.9M1.7%———
Increased
56
??H WORLD GROUP LTDDelisted
Bond
112M$129.1M1.3%———
Decreased
0
??Dayforce IncDelisted
Bond
142.6M$125.9M1.3%———
Unchanged
0
??SNAP INC
Bond
177.8M$123.3M1.3%———
Increased
55
167.3M$122.5M1.3%——
3 qtrssince 2023-Q1
Increased
48
153.9M$117.1M1.2%———
Increased
60
130.4M$111.5M1.1%———
Increased
48
??LYFT, INC.Delisted
Bond
119.6M$110.2M1.1%———
Increased
47
136.3M$109M1.1%———
Increased
48
$9.7B
AUM
374
Positions
Q3 2023
Filing
HI score · 2.5/5
Quarterly 13F Value Change
-32%Q2'22$10.9B+0%Q3'22$10.9B-13%Q4'22$9.5B-0%Q1'23$9.5B+0%Q2'23$9.5B+2%Q3'23$9.7B
Activity profile
$ moved · Q3'23
New31%Increased23%Decreased20%Exited26%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.5 years
<1Q8%1-4Q22%1-2Y40%2Y+30%

LINDEN ADVISORS LP manages $9.7B across 374 positions as of Q3 2023. Top holdings: PINDUODUO INC (3.9%), LI AUTO INC (2.9%), WOLFSPEED INC (2.9%). Fund DNA: Diversified Scout. HoldingsIntel Score: 2.5/5.0.

Q3 2023 Summary

Active quarter - 48 new positions, 72 exits, 84 increased. No standout high-conviction moves this quarter. Portfolio: $9.7B across 374 positions.

Top holdings by portfolio weight

Total AUM$10B
PINDUODUO IN3.93%
LI AUTO INC2.92%
WOLFSPEED IN2.91%
SEA LTD2.69%
MONGODB INC1.95%
BILL.COM HOL1.88%
BILIBILI INC1.83%
Sarepta Ther1.77%
LIVONGO HEAL1.77%
ROYAL CARIBB1.75%
Other1.70%

Portfolio allocation by GICS sector

Sectors8
Unknown46.47%
Technology25.74%
Financial Services19.09%
Basic Materials4.28%
Consumer Cyclical3.76%
Energy0.61%
Industrials0.04%
Healthcare0.01%

Behavioral investing profile

Checking access…
Diversified Scout
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Solid(2.5 / 5.0)
Holdings P&L57
Conviction31
Concentration37
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
BR10806XAD4BRIDGEBIO PHARMA INC
Q4 2024 → Q2 2026+151.4M shares+$192.5M
7Q
VI928298AR9VISHAY INTERTECHNOLOGY INC.
Q4 2024 → Q2 2026+353.9M shares+$770.5M
4Q
CO19459JAC8COLLEGIUM PHARMACEUTICAL INC
Q3 2025 → Q2 2026+26.6M shares+$50.6M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used